A Study To Test If Dronapushpi Arka Nebulization Helps Treat Bronchial Asthma In Children.

Randomized Controlled Clinical Study To Evaluate The Efficacy Of Dronapushpi Arka Nebulization In Tamakashwasa With Special Reference To Bronchial Asthma In Children. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087352

Enrollment

Registered

2025-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children Of Age Group 6-11 Years, Irrespective Of Gender, Religion And Socio Economic Status Will Be Included. 2. Children With Mild To Moderate Exacerbations Of Asthma Will Be Included. 3. Children Whose Parents Are Willing To Sign The Written Consent Form Will Be Included.

Exclusion criteria

Exclusion criteria: 1. Children With Severe Exacerbations Of Asthma Will Be Excluded. 2. Children With Known Case Of Tuberculosis, Emphysema, COPD Will Be Excluded.

Design outcomes

Primary

Measure	Time frame
To clinically evaluate and compare the efficacy of Dronapushpi Arka and Parnayavani Arka nebulization in the management of Tamaka Shwasa (Bronchial Asthma) in children, based on the outcomes assessed through GINA (Global Initiative for Asthma) scoring.Timepoint: 0TH day,7TH day,9TH day	—

Secondary

Measure	Time frame
1.To Do A Detailed Literary Review Of Tamaka Shwasa. 2.To Monitor The Adverse Drug Reaction. Timepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Deshpande Sharavari Sunil

Sri Sri College of Ayurvedic Science and Research Hospital, Bangalore

gawandesahil0298@gmail.com8857875561

Outcome results